This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 3 CIPO patents. Top assignee: Cogent Biosciences, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: John I Trujillo: Innovator in Pharmaceutical Science
Introduction
John I Trujillo is a notable inventor based in Boulder, Colorado. He has made significant contributions to the field of pharmaceutical science, particularly in the development of PI3K inhibitors. His work focuses on compounds that have the potential to treat various diseases effectively.
Latest Patents
Trujillo holds a patent for PI3K inhibitors, which describes a compound with a specific structure and its stereoisomers, tautomers, and pharmaceutically acceptable salts. The patent outlines the pharmaceutical composition comprising these compounds and their applications in treating diseases.
Career Highlights
Trujillo is currently associated with Cogent Biosciences, Inc., where he continues to advance his research and development efforts. His expertise in pharmaceutical compositions has positioned him as a valuable asset in the industry.
Collaborations
Some of his notable coworkers include Payal Chatterjee and Mark Joseph Chicarelli, who contribute to the innovative environment at Cogent Biosciences, Inc.
Conclusion
John I Trujillo's work in developing PI3K inhibitors showcases his commitment to advancing pharmaceutical science. His contributions are vital in the ongoing efforts to find effective treatments for various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile